Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Utilities Select Sector SPDR Fund — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Utilities Select Sector SPDR Fund trades at $42.01 (market cap $24.38B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 2.7× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Utilities Select Sector SPDR Fund for 81 Days on average.
| KYMR | XLU | |
|---|---|---|
Market Cap | $8.88B | $24.38B |
Volume | 1,028,790 | 35,403,779 |
Sector | Health | — |
52-Week High | $127.31 | $47.73 |
52-Week Low | $55.80 | $39.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $8.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLU, the Utilities Select Sector SPDR ETF, trades at $41.87, up 0.58% on the day, but remains near 52-week lows amid sector-wide pressure from rising interest rates. Technical signals are mixed with a bullish moving average crossover but bearish oscillators, including an overbought RSI. The ETF offers exposure to defensive utility stocks but faces headwinds from higher yields compressing dividend appeal and regulatory uncertainty around AI-driven power demand.
The outlook for XLU is cautious near-term due to interest rate sensitivity and oversold sector conditions, though long-term defensive characteristics and potential AI infrastructure demand provide a counterbalance. Key risks include prolonged high rates eroding utility valuations, while opportunities lie in any pivot to defensive assets during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
